-
Chardan Capital Reaffirms Buy Rating for Seres Therapeutics (NASDAQ:MCRB)
Источник: Buzz FX / 21 мар 2025 17:02:18 America/New_York
Chardan Capital Reaffirms Buy Rating for Seres Therapeutics (NASDAQ:MCRB) Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads Seres Therapeutics ( NASDAQ:MCRB - Get Free Report ) 's stock had its "buy" rating rei
Read more...